317 related articles for article (PubMed ID: 23812328)
1. Innate immune responses against Epstein Barr virus infection.
Chijioke O; Azzi T; Nadal D; Münz C
J Leukoc Biol; 2013 Dec; 94(6):1185-90. PubMed ID: 23812328
[TBL] [Abstract][Full Text] [Related]
2. Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases.
Abbott RJ; Pachnio A; Pedroza-Pacheco I; Leese AM; Begum J; Long HM; Croom-Carter D; Stacey A; Moss PAH; Hislop AD; Borrow P; Rickinson AB; Bell AI
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835490
[TBL] [Abstract][Full Text] [Related]
3. The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells.
Westhoff Smith D; Chakravorty A; Hayes M; Hammerschmidt W; Sugden B
mBio; 2021 Dec; 12(6):e0224321. PubMed ID: 34781735
[TBL] [Abstract][Full Text] [Related]
4. Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells.
Djaoud Z; Guethlein LA; Horowitz A; Azzi T; Nemat-Gorgani N; Olive D; Nadal D; Norman PJ; Münz C; Parham P
J Exp Med; 2017 Jun; 214(6):1827-1841. PubMed ID: 28468758
[TBL] [Abstract][Full Text] [Related]
5. Natural Killer cell transcriptome during primary EBV infection and EBV associated Hodgkin Lymphoma in children-A preliminary observation.
M A; Chatterjee S; A P; S M; Davuluri S; Ar AK; T A; M P; Cs P; Sinha M; Chugani A; R VP; Kk A; R S J
Immunobiology; 2020 May; 225(3):151907. PubMed ID: 32044149
[TBL] [Abstract][Full Text] [Related]
6. Innate Immune Recognition of EBV.
Lünemann A; Rowe M; Nadal D
Curr Top Microbiol Immunol; 2015; 391():265-87. PubMed ID: 26428378
[TBL] [Abstract][Full Text] [Related]
7. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
Front Immunol; 2020; 11():1231. PubMed ID: 32625211
[TBL] [Abstract][Full Text] [Related]
8. Contrasting roles of dendritic cells and B cells in the immune control of Epstein-Barr virus.
Bickham K; Münz C
Curr Top Microbiol Immunol; 2003; 276():55-76. PubMed ID: 12797443
[TBL] [Abstract][Full Text] [Related]
9. [Chronic active Epstein-Barr virus infection].
Kimura H
Uirusu; 2011 Dec; 61(2):163-73. PubMed ID: 22916563
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity in Epstein Barr virus specific immune control.
Münz C
Curr Opin Virol; 2021 Feb; 46():1-8. PubMed ID: 32771660
[TBL] [Abstract][Full Text] [Related]
12. The immune response to primary EBV infection: a role for natural killer cells.
Williams H; McAulay K; Macsween KF; Gallacher NJ; Higgins CD; Harrison N; Swerdlow AJ; Crawford DH
Br J Haematol; 2005 Apr; 129(2):266-74. PubMed ID: 15813855
[TBL] [Abstract][Full Text] [Related]
13. The immunology of Epstein-Barr virus-induced disease.
Taylor GS; Long HM; Brooks JM; Rickinson AB; Hislop AD
Annu Rev Immunol; 2015; 33():787-821. PubMed ID: 25706097
[TBL] [Abstract][Full Text] [Related]
14. Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γ.
Jud A; Kotur M; Berger C; Gysin C; Nadal D; Lünemann A
Oncotarget; 2017 Jan; 8(4):6130-6141. PubMed ID: 28008151
[TBL] [Abstract][Full Text] [Related]
15. Induction of the Lytic Cycle Sensitizes Epstein-Barr Virus-Infected B Cells to NK Cell Killing That Is Counteracted by Virus-Mediated NK Cell Evasion Mechanisms in the Late Lytic Cycle.
Williams LR; Quinn LL; Rowe M; Zuo J
J Virol; 2016 Jan; 90(2):947-58. PubMed ID: 26537677
[TBL] [Abstract][Full Text] [Related]
16. Innate immune control of EBV-infected B cells by invariant natural killer T cells.
Chung BK; Tsai K; Allan LL; Zheng DJ; Nie JC; Biggs CM; Hasan MR; Kozak FK; van den Elzen P; Priatel JJ; Tan R
Blood; 2013 Oct; 122(15):2600-8. PubMed ID: 23974196
[TBL] [Abstract][Full Text] [Related]
17. Role for early-differentiated natural killer cells in infectious mononucleosis.
Azzi T; Lünemann A; Murer A; Ueda S; Béziat V; Malmberg KJ; Staubli G; Gysin C; Berger C; Münz C; Chijioke O; Nadal D
Blood; 2014 Oct; 124(16):2533-43. PubMed ID: 25205117
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes.
Farina A; Peruzzi G; Lacconi V; Lenna S; Quarta S; Rosato E; Vestri AR; York M; Dreyfus DH; Faggioni A; Morrone S; Trojanowska M; Farina GA
Arthritis Res Ther; 2017 Feb; 19(1):39. PubMed ID: 28245863
[TBL] [Abstract][Full Text] [Related]
19. The Role of NK Cells in EBV Infection and EBV-Associated NPC.
Png YT; Yang AZY; Lee MY; Chua MJM; Lim CM
Viruses; 2021 Feb; 13(2):. PubMed ID: 33671917
[TBL] [Abstract][Full Text] [Related]
20. [Anything that can go wrong: cytotoxic cells and their control of Epstein-Barr virus].
Gutiérrez-Guerrero A; Espinosa-Padilla SE; Lugo-Reyes SO
Rev Alerg Mex; 2024 Feb; 71(1):29-39. PubMed ID: 38683066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]